A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine
NCT01224002 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2012-11-21
Summary
The prevalence and severity of dental caries in incarcerated people who abuse drugs are unknown but an inmate reporting to the dental clinic typically presents with myriad findings: oral signs of uncontrolled decay on the buccal smooth surfaces of the posterior teeth and interproximal surfaces of the anterior teeth, excessive tooth wear due to grinding and clenching, and gingival inflammation. The primary risk factors for the development of caries appear to be the combination of xerostomia, frequent consumption of carbonated soft drinks, high dental plaque levels and nonexistent or inadequate oral hygiene. Since some of these findings are seen in the other disease states, specifically in substance abuse cases, the diagnosis is often not clear. The objective of the project is to design a cross sectional comparative feasibility study that will estimate the prevalence, pattern, and severity of untreated dental decay for three types of inmates: methamphetamine abusers, substance abusers not identified as methamphetamine users, and non-substance abusers, focusing in on methamphetamine abusers as the highest risk group.
Recruitment will be accomplished using a 2-phased process. Phase I. An invitation letter explaining the study purpose and its relevance to oral health in a correctional setting will be mailed to the inmate population at two Federal Bureau of Prisons' institutions who entered the prison system during the first half of 2009. Dublin, a female FCI located in Northern California and Butner, a male FCC located in North Carolina were the selected facilities due to the high incidence of drug abusers among their inmates. The letter, which will invite all inmates to participate in the study, will inform the inmate should they consent to participate in the study that they will have their existing dental record confirmed, Central File reviewed for DSM-IV diagnosis pertinent to the study, and that they will be given a study questionnaire. Positive responses to the invitation letters will be returned to Dr. Johnson at head quarters in Washington DC. The psychology division will code the volunteer inmates into the three study groups.
Phase II. The first 30 chronologically documented volunteers in each study group category will be scheduled an appointment. A consent form will be read and explained to each inmate, in either English or Spanish as appropriate and his/her signature obtained as his/her informed consent.
Each question on the study questionnaire will be read to the inmate volunteer and the Research Associate will record the answer. A retrospective comparative study will then be employed utilizing the inmate's initial dental intake exam (routinely administered by the Federal Bureau of Prisons' dental department). The dental chart will be abstracted for dental caries. The pattern of surface-specific dental caries (DFS index) will be described and analyzed. The focus will be on the levels of untreated and treated disease diagnosed in a 4-zone partition of the oral dentition, representing a modification of the zones identified in the Grainger's caries severity index scoring system as this partition allows focus on decay patterns of anterior tooth surfaces. The multivariate summary of disease levels within each zone will be derived and statistically compared across the three study groups using Hotelling's t2-test (the multivariate extension of the Student-t test). The results of the study will be used to do a preliminary assessment between methamphetamine drug abuse and oral health and determine whether a prospective clinical study is warranted.
Conditions
- Substance-Related Disorders
- Dental Caries
Sponsors & Collaborators
-
National Institute of Dental and Craniofacial Research (NIDCR)
lead NIH
Principal Investigators
-
J. Silvio Gutkind, Ph.D. · National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-09-30
- Completion
- 2012-11-30
More Related Trials
-
NAC as a Potential Treatment for Methamphetamine Dependence
NCT01063205 ·Status: COMPLETED ·Phase: PHASE1
-
An Eval of Neurocognitive Function, Oxidative Damage, and Their Association With Outcomes in METH and Cocaine Abusers.
NCT00628927 ·Status: COMPLETED
-
n-Acetylcysteine and Cocaine
NCT02141620 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Modafinil in Methamphetamine Dependence
NCT00751023 ·Status: COMPLETED ·Phase: PHASE4
-
Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5
NCT00015223 ·Status: COMPLETED ·Phase: PHASE2
-
Non-Treatment Study of Factors Affecting Cocaine Drug Choice
NCT00946660 ·Status: COMPLETED
-
N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence
NCT00332605 ·Status: COMPLETED ·Phase: PHASE2
-
Acute Withdrawal From Smoked Cocaine - 9
NCT00000292 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1
NCT00136825 ·Status: COMPLETED ·Phase: PHASE1
-
"The Evaluation of Stimulant Withdrawal"
NCT00442923 ·Status: WITHDRAWN ·Phase: PHASE2
-
Open-Label Creatine Study for Female Meth Users
NCT02189915 ·Status: TERMINATED ·Phase: NA
-
Functional Connectivity Changes During Early Recovery as a Marker for Relapse
NCT02861820 ·Status: COMPLETED
-
Studying Amphetamine Withdrawal in Humans
NCT01215929 ·Status: COMPLETED ·Phase: PHASE2
-
Brain Changes in Stimulant Dependent Subjects - 8
NCT00000343 ·Status: COMPLETED ·Phase: PHASE4
-
Modafinil Treatment for Cocaine-Dependent Individuals
NCT00129285 ·Status: COMPLETED ·Phase: PHASE2
-
Cocaine Withdrawal and Pharmacotherapy Response
NCT00566969 ·Status: COMPLETED ·Phase: NA
-
Methylphenidate to Treat Methamphetamine Dependence
NCT01044238 ·Status: UNKNOWN ·Phase: PHASE2
-
Disulfiram for Cocaine Abuse in Buprenorphine Treatment
NCT00913484 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo
NCT00218348 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Trial of Dextroamphetamine for Methamphetamine Dependence
NCT00630682 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of a Non-Drug Choice on Cocaine Reinforcement
NCT01906346 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Creatine as a Treatment Option for Depression in Methamphetamine Using Females
NCT01514630 ·Status: COMPLETED ·Phase: PHASE4
-
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1
NCT00142844 ·Status: COMPLETED ·Phase: PHASE2
-
A Feasibility Trial for Inhibitory-Control Training to Reduce Cocaine Use
NCT02444208 ·Status: COMPLETED ·Phase: NA
-
Carbamazepine Treatment of Cocaine Dependence - 1
NCT00000242 ·Status: COMPLETED ·Phase: PHASE2